Concord Biotech

Market Cap: Small Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE338H01029
NSEID: CONCORDBIO
BSEID: 543960
View on NSE | View on BSE

INR

1,039.10

1.6 (0.15%)

BSENSE

Mar 25

BSE+NSE Vol: 2.31 lacs

{
  "main_header": {
    "sid": 10038977,
    "name": "Concord Biotech",
    "stock_name": "Concord Biotech",
    "full_name": "Concord Biotech Ltd",
    "name_url": "stocks-analysis/concord-biotech",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,039.10",
    "chg": 1.6,
    "chgp": "0.15%",
    "dir": 1,
    "prev_price": "1,037.50",
    "mcapval": "11,099.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 543960,
    "symbol": "CONCORDBIO",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE338H01029",
    "curr_date": "Mar 25",
    "curr_time": "",
    "bse_nse_vol": "2.31 lacs",
    "exc_status": "Active",
    "traded_date": "Mar 25, 2026",
    "traded_date_str": "2026 03 25",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/concord-biotech-10038977-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Five Consecutive Losses Push Concord Biotech Ltd to a New 52-Week Low",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/concord-biotech-ltd-falls-to-52-week-low-amid-continued-downtrend-3908126",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/ConcordBiotechL_priceRelatedfactors_3908126.png",
        "date": "2026-03-23 13:55:09",
        "description": "For the fifth straight session, Concord Biotech Ltd closed lower, breaching its 52-week low at Rs 1,045.9 on 23 Mar 2026. This marks a significant decline amid a broader market downturn, with the stock falling 8.07% over the last three days alone."
      },
      {
        "title": "Concord Biotech Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/concord-biotech-ltd-is-rated-strong-sell-3893173",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/ConcordBiotechL_mojoScore_3893173.png",
        "date": "2026-03-16 10:10:47",
        "description": "Concord Biotech Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 04 March 2026, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed here are current as of 16 March 2026, providing investors with the latest perspective on the company’s position."
      },
      {
        "title": "Concord Biotech Declines 1.25% Amid Bearish Technicals and Downgrade",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/concord-biotech-declines-125-amid-bearish-technicals-and-downgrade-3878059",
        "imagepath": "",
        "date": "2026-03-07 11:02:50",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>Mar 02:</strong> Stock opens at Rs.1,221.55, declines 1.83% amid broad market sell-off</p>\n                    <p><strong>Mar 04:</strong> Technical indicators signal bearish momentum; stock gains 0.50%</p>\n                    <p><strong>Mar 05:</strong> Downgrade to Strong Sell by MarketsMOJO announced; stock slips 0.23%</p>\n                    <p><strong>Mar 06:</strong> Week closes at Rs.1,206.30, up 0.32% on the day but down for the week</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,221.55</div></div>\n                    <div class=\"stat-item\"><d..."
      },
      {
        "title": "Concord Biotech Downgraded to Strong Sell Amid Weak Financials and Bearish Technicals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/concord-biotech-downgraded-to-strong-sell-amid-weak-financials-and-bearish-technicals-3872904",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/ConcordBiotechL_mojoScore_3872904.png",
        "date": "2026-03-05 08:33:48",
        "description": "Concord Biotech Ltd has been downgraded from a Sell to a Strong Sell rating as of 4 March 2026, reflecting deteriorating fundamentals and increasingly bearish technical indicators. The pharmaceutical and biotechnology company’s Mojo Score has declined to 28.0, signalling heightened risk for investors amid sustained negative financial trends and unfavourable market signals."
      },
      {
        "title": "Concord Biotech Ltd Faces Bearish Momentum Amid Technical Indicator Deterioration",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/concord-biotech-ltd-faces-bearish-momentum-amid-technical-indicator-deterioration-3868391",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/ConcordBiotechL_technicaldot_3868391.png",
        "date": "2026-03-04 08:07:32",
        "description": "Concord Biotech Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a bearish trend. Despite recent short-term gains, the stock’s overall technical profile has deteriorated, prompting a downgrade in its Mojo Grade to Sell from Strong Sell as of 26 Feb 2026."
      },
      {
        "title": "Concord Biotech Ltd Gains 11.13%: 5 Key Factors Driving the Weekly Surge",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/concord-biotech-ltd-gains-1113-5-key-factors-driving-the-weekly-surge-3861933",
        "imagepath": "",
        "date": "2026-02-28 10:02:37",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>23 Feb:</strong> Stock hits 52-week low of Rs.1,090.85 amid bearish technicals</p>\n                    <p><strong>24 Feb:</strong> Further decline to Rs.1,079 with downgrade to Strong Sell</p>\n                    <p><strong>25 Feb:</strong> Intraday low of Rs.1,056.75 followed by strong 8.15% surge</p>\n                    <p><strong>26 Feb:</strong> High-value trading with mixed price action, closing near Rs.1,218.85</p>\n                    <p><strong>27 Feb:</strong> Mildly bearish technical shift with 2.31% gain to Rs.1,246.95</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div..."
      },
      {
        "title": "Concord Biotech Ltd Sees Technical Momentum Shift Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/concord-biotech-ltd-sees-technical-momentum-shift-amid-mixed-market-signals-3859580",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/ConcordBiotechL_technicaldot_3859580.png",
        "date": "2026-02-27 08:02:49",
        "description": "Concord Biotech Ltd has experienced a subtle shift in its technical momentum, moving from a bearish to a mildly bearish stance, reflecting a complex interplay of technical indicators. Despite a positive day change of 2.31%, the stock remains under pressure with a Mojo Grade of Sell, signalling cautious investor sentiment amid mixed signals from key momentum and trend indicators."
      },
      {
        "title": "Concord Biotech Ltd Sees High-Value Trading Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/concord-biotech-ltd-sees-high-value-trading-amid-mixed-market-signals-3857652",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/ConcordBiotechL_most_active_equities_by_value_3857652.png",
        "date": "2026-02-26 10:00:25",
        "description": "Concord Biotech Ltd emerged as one of the most actively traded stocks by value on 26 Feb 2026, registering a total traded volume of over 15.9 lakh shares and a turnover exceeding ₹195 crore. Despite this robust trading activity, the stock underperformed its sector and broader market indices, reflecting a complex interplay of investor sentiment and institutional interest in the pharmaceuticals and biotechnology space."
      },
      {
        "title": "Concord Biotech Ltd Surges on Heavy Value Trading Amid Mixed Technical Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/concord-biotech-ltd-surges-on-heavy-value-trading-amid-mixed-technical-signals-3855761",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/ConcordBiotechL_most_active_equities_by_value_3855761.png",
        "date": "2026-02-25 14:00:13",
        "description": "Concord Biotech Ltd witnessed a remarkable surge in trading activity on 25 Feb 2026, emerging as one of the highest value stocks on the bourses. The pharmaceutical and biotechnology company’s shares soared by 13.38%, driven by robust institutional participation and significant order flow, signalling renewed investor interest despite a recent downgrade in its mojo rating."
      }
    ],
    "total": 383,
    "sid": "10038977",
    "stock_news_url": "https://www.marketsmojo.com/news/concord-biotech-10038977"
  },
  "announcements": "",
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Concord Biotech Ltd has declared <strong>1070%</strong> dividend, ex-date: 03 Sep 25",
          "dt": "2025-09-03",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Five Consecutive Losses Push Concord Biotech Ltd to a New 52-Week Low

2026-03-23 13:55:09

For the fifth straight session, Concord Biotech Ltd closed lower, breaching its 52-week low at Rs 1,045.9 on 23 Mar 2026. This marks a significant decline amid a broader market downturn, with the stock falling 8.07% over the last three days alone.

Read full news article

Concord Biotech Ltd is Rated Strong Sell

2026-03-16 10:10:47

Concord Biotech Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 04 March 2026, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed here are current as of 16 March 2026, providing investors with the latest perspective on the company’s position.

Read full news article

Concord Biotech Declines 1.25% Amid Bearish Technicals and Downgrade

2026-03-07 11:02:50

Key Events This Week

Mar 02: Stock opens at Rs.1,221.55, declines 1.83% amid broad market sell-off

Mar 04: Technical indicators signal bearish momentum; stock gains 0.50%

Mar 05: Downgrade to Strong Sell by MarketsMOJO announced; stock slips 0.23%

Mar 06: Week closes at Rs.1,206.30, up 0.32% on the day but down for the week

Week Open

Rs.1,221.55

Read full news article

Concord Biotech Downgraded to Strong Sell Amid Weak Financials and Bearish Technicals

2026-03-05 08:33:48

Concord Biotech Ltd has been downgraded from a Sell to a Strong Sell rating as of 4 March 2026, reflecting deteriorating fundamentals and increasingly bearish technical indicators. The pharmaceutical and biotechnology company’s Mojo Score has declined to 28.0, signalling heightened risk for investors amid sustained negative financial trends and unfavourable market signals.

Read full news article

Concord Biotech Ltd Faces Bearish Momentum Amid Technical Indicator Deterioration

2026-03-04 08:07:32

Concord Biotech Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a bearish trend. Despite recent short-term gains, the stock’s overall technical profile has deteriorated, prompting a downgrade in its Mojo Grade to Sell from Strong Sell as of 26 Feb 2026.

Read full news article

Concord Biotech Ltd Gains 11.13%: 5 Key Factors Driving the Weekly Surge

2026-02-28 10:02:37

Key Events This Week

23 Feb: Stock hits 52-week low of Rs.1,090.85 amid bearish technicals

24 Feb: Further decline to Rs.1,079 with downgrade to Strong Sell

25 Feb: Intraday low of Rs.1,056.75 followed by strong 8.15% surge

26 Feb: High-value trading with mixed price action, closing near Rs.1,218.85

27 Feb: Mildly bearish technical shift with 2.31% gain to Rs.1,246.95

Week Open

Read full news article

Concord Biotech Ltd Sees Technical Momentum Shift Amid Mixed Market Signals

2026-02-27 08:02:49

Concord Biotech Ltd has experienced a subtle shift in its technical momentum, moving from a bearish to a mildly bearish stance, reflecting a complex interplay of technical indicators. Despite a positive day change of 2.31%, the stock remains under pressure with a Mojo Grade of Sell, signalling cautious investor sentiment amid mixed signals from key momentum and trend indicators.

Read full news article

Concord Biotech Ltd Sees High-Value Trading Amid Mixed Market Signals

2026-02-26 10:00:25

Concord Biotech Ltd emerged as one of the most actively traded stocks by value on 26 Feb 2026, registering a total traded volume of over 15.9 lakh shares and a turnover exceeding ₹195 crore. Despite this robust trading activity, the stock underperformed its sector and broader market indices, reflecting a complex interplay of investor sentiment and institutional interest in the pharmaceuticals and biotechnology space.

Read full news article

Concord Biotech Ltd Surges on Heavy Value Trading Amid Mixed Technical Signals

2026-02-25 14:00:13

Concord Biotech Ltd witnessed a remarkable surge in trading activity on 25 Feb 2026, emerging as one of the highest value stocks on the bourses. The pharmaceutical and biotechnology company’s shares soared by 13.38%, driven by robust institutional participation and significant order flow, signalling renewed investor interest despite a recent downgrade in its mojo rating.